Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
about
Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomasRetinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantationHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaRapid COJEC versus standard induction therapies for high-risk neuroblastomaRapid COJEC versus standard induction therapies for high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaIodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastomaRetinoic acid post consolidation therapy for high-risk neuroblastomaMIBG scintigraphy and PET imaging for diagnosing neuroblastomaDifferentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotypeIdentification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysisOutcome after reduced chemotherapy for intermediate-risk neuroblastomaCopy number variation at 1q21.1 associated with neuroblastomaAnalyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumoursImplications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaSmall round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface moleculeChromosome 6p22 locus associated with clinically aggressive neuroblastomaLong-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group studyIntroduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell deathThe Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case SeriesProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaNovel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA librariesExpression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsetsAutomatic detection and genetic profiling of disseminated neuroblastoma cellsNovel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma libraryIncreased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomasPlasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patientsTreatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapyCombined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High AccuracyHOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptomeIdentification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cellsTargeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkBCommon variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaOverview and recent advances in the treatment of neuroblastoma.Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing.Cochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children.PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastomaNeuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction.
P2860
Q21245646-26E4108A-E7D4-4F71-9A49-0589D2DC9520Q24186451-A62FA0D3-D484-41F3-A881-11E6D97931B6Q24186636-0327C7F4-1932-44C0-AD7A-9A2855140B00Q24186888-1C246DE6-E860-4F86-AF56-D67E665B611EQ24187922-3BF00A34-88FA-48B9-ABF2-5E43CF7D1653Q24197871-37DA0DA8-B5B1-4E44-A545-05229F4BD5AEQ24200296-E3A86F08-B117-4736-9CC9-3BC01885F3C3Q24201280-43794300-10C7-44D0-84DB-AD448746E915Q24201495-87503154-A389-43FA-93AB-9D7FB12C6324Q24234571-3E13DC81-CEED-4D60-8FA1-D22FF0922E73Q24300732-E4946901-C47D-44F0-B739-28A11F7F57F0Q24562910-4C2981CB-7B12-4568-ADA1-86FFAFDA015FQ24633964-D285E7DE-2AAE-41F1-9BB1-AFAE9A651F40Q24642330-452A9404-1752-49CC-9581-C1AD74534FBBQ24642923-92D2460A-4EFE-48DE-92A5-7A1D2B9510EBQ24647476-AD2E483A-F66E-4A41-8D2A-4D3BA6D7D9B2Q24655582-62D2E204-3448-4029-AEE6-5E2359386453Q24656264-2D58E70A-58A2-41D3-9C4E-F55C0F8BEAC1Q24658339-1D5DB5A8-93AF-4416-89E6-06413BE1A215Q25257689-3B2C233D-D49E-4559-AC82-E1F6D8008EB0Q26769681-EB9D5407-EC32-4899-B437-6CE1E83BD77BQ28069952-F9936E44-682A-4EE1-9803-7C73F349AF65Q28178383-491B0E4A-DB40-41E3-8A64-4723F38FA700Q28203137-AE7C2EE6-2B19-4E44-8073-D944FFA68067Q28207808-3171E61E-541A-4F6F-97F9-CDB34EF74C32Q28220472-2338120C-42A5-470E-99AF-FC95038EDD37Q28281864-702EF992-007D-43B4-AB36-FDE775AEBBF0Q28304289-809E7BB8-4700-42D4-9CF3-122886143556Q28350866-4645A3D5-51DC-4FEB-AFD7-4F12690A8CCFQ28546522-B9993A4E-3092-46D9-96EC-7642D2714911Q28652372-7C392C04-C82C-4B13-A3B9-B31D27DF3A9DQ28740435-478EA9FE-8570-4215-B2E3-8F34C4908609Q28818744-1F510AFB-B6D5-4EBF-BB26-B1FE70F1F1DEQ28943271-BB484EE2-1021-4085-87A5-10DD680B851FQ30238693-FF5D8F37-68D5-47AB-B6A3-74FC80AED7BCQ30239861-3BA2C891-AF6A-4496-B2D1-5DDF66EECA1AQ30391060-8FE4F0A5-DE8B-4DF7-B84E-BA845CD2DBB7Q30397139-A2AA6EA9-0E40-4D47-81E8-A8CEF1C7B9FFQ30417536-EDBD9030-3FF5-49BA-958B-8DBC15B4ABA4Q30536922-69972C4B-DC2E-46E6-9C62-6E94A593BC0E
P2860
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Revisions of the international ...... ng, and response to treatment.
@ast
Revisions of the international ...... ng, and response to treatment.
@en
Revisions of the international ...... ng, and response to treatment.
@nl
type
label
Revisions of the international ...... ng, and response to treatment.
@ast
Revisions of the international ...... ng, and response to treatment.
@en
Revisions of the international ...... ng, and response to treatment.
@nl
prefLabel
Revisions of the international ...... ng, and response to treatment.
@ast
Revisions of the international ...... ng, and response to treatment.
@en
Revisions of the international ...... ng, and response to treatment.
@nl
P2093
P1476
Revisions of the international ...... ing, and response to treatment
@en
P2093
B De Bernardi
F Berthold
G M Brodeur
J Pritchard
N L Carlsen
R P Castelberry
P304
P356
10.1200/JCO.1993.11.8.1466
P407
P577
1993-08-01T00:00:00Z